Table 2.
Univariate and multivariate Cox analyses for miR-638 in breast cancer patients
| Characteristics | Univariate analyses
|
Multivariate analysis
|
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | |
|
| ||||||
| miR-638 | 0.325 | 0.119–0.886 | 0.028 | 0.325 | 0.119–0.886 | 0.028 |
| Age | 1.828 | 0.857–3.900 | 0.119 | – | – | – |
| Tumor size | 1.067 | 0.464–2.454 | 0.879 | – | – | – |
| ER status | 1.221 | 0.547–2.728 | 0.626 | – | – | – |
| PR status | 0.798 | 0.323–1.970 | 0.625 | – | – | – |
| HER-2 status | 1.634 | 0.743–3.592 | 0.222 | – | – | – |
| Lymph node metastasis | 0.799 | 0.337–1.894 | 0.611 | – | – | – |
| TNM stage | 1.521 | 0.721–3.210 | 0.271 | – | – | – |
Note: –, indicated no related data.
Abbreviations: ER, estrogen receptor; HR, hazard ratio; PR, progesterone receptor.